Abstract
Background
Angiotensin II type 1 (AT1) receptor-antagonists are widely used for treatment of hypertension. Recent studies have demonstrated a protective effect of renin angiotensin system (RAS) antagonism against immune-mediated inflammatory diseases such as myocarditis, chronic allograft rejection, antiglomerular basement membrane nephritis, colitis, and arthritis. However, only a few reports have demonstrated the effect of RAS in ocular inflammatory conditions. The purpose of this study was to investigate the anti-inflammatory effect of a selective AT1 receptor antagonist, losartan, on endotoxin-induced uveitis (EIU) and compare the effect on experimental autoimmune uveoretinitis (EAU).
Methods
To induce EIU, 7-week-old Lewis rats were injected subcutaneously with 200 μg lipopolysaccharide (LPS). Losartan was administered intravenously at the same time. The aqueous humor was collected from eyes 24 h after LPS injection. The number of infiltrating cells, protein concentration, and levels of tumor necrosis factor (TNF)-α and monocyte chemoattractant protein-1 (MCP-1) in the aqueous humor were determined. The collected eyes were immunohistochemically stained with monoclonal antibody for activated nuclear factor (NF)-κB. To induce EAU, C57BL/6 mice (6–8 weeks old) were immunized with human interphotoreceptor retinoid binding protein (hIRBP)-derived peptide emulsified in complete Freund’s adjuvant (CFA) and concomitantly injected with purified Bordetella pertussis toxin (PTX). Clinical severity of EAU and T cell proliferative response were analyzed.
Results
Losartan significantly suppressed the development of EIU. Numbers of aqueous cells of control EIU rats, those from EIU rats treated with 1 or 10 mg/kg of losratan were 75.3 ± 45.6 × 105, 27.9 ± 8.1 × 105, or 41.3 ± 30.9 × 105 cells/ml respectively (p < 0.01 vs control). Aqueous protein, TNF-α, and MCP-1 levels were also significantly decreased in a manner dependent on the amount of losartan administered (p < 0.01). Treatment of EIU rats with losartan suppressed activation of NF-κB at the iris ciliary body. Thus, the suppressive effect of losartan on ocular inflammation in EIU appeared to result from down-regulation of NF-κB activation and reduction of inflammatory cytokine production. On the other hand, in the EAU model, neither the clinical score nor the antigen-specific T cell proliferative response was significantly influenced by the treatment with losartan.
Conclusions
The present findings indicate that RAS may be involved in the acute inflammation of the eye, but not in T cell-dependent ocular autoimmunity. Antagonism of the RAS may be a potential prophylactic strategy for treatment of the human acute ocular inflammation.
Similar content being viewed by others
References
Amuchastegui SC, Azzollini N, Mister M, Pezzotta A, Perico N, Remuzzi G (1998) Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism. J Am Soc Nephrol 9:1948–1955
Andersson P, Cederholm T, Johansson AS, Palmblad J (2002) Captopril-impaired production of tumor necrosis factor-α-induced interleukin-1β in human monocytes is associated with altered intracellular distribution of nuclear factor-κB. J Lab Clin Med 140:103–109
Baldwin AS Jr (1996) The NF-κB and I κB proteins: new discoveries and insights. Annu Rev Immunol 14:649–683
Barnes PJ (1997) Nuclear factor-κB. Int J Biochem Cell Biol 29:867–870
Barnes PJ, Karin M (1997) Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066–1071
Benediktsson H, Chea R, Davidoff A, Paul LC (1996) Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function. Transplantation 62:1634–1642
Caspi RR, Roberge FG, McAllister CG, el-Saied M, Kuwabara T, Gery I, Hanna E, Nussenblatt RB (1986) T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol 136:928–933
Caspi RR, Roberge FG, Chan CC, Wiggert B, Chader GJ, Rozenszajn LA, Lando Z, Nussenblatt RB (1988) A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 140:1490–1495
Chan CC, Tuaillon N, Li Q, Shen DF (2000) Therapeutic applications of antiflammin peptides in experimental ocular inflammation. Ann N Y Acad Sci 923:141–146
Chiu AT, Dunscomb J, Kosierowski J, Burton CR, Santomenna LD, Corjay MH, Benfield P (1993) The ligand binding signatures of the rat AT1A, AT1B and the human AT1 receptors are essentially identical. Biochem Biophys Res Commun 197:440–449
Chua CC, Hamdy RC, Chua BH (1998) Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1401:187–194
de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415–472
de Vos AF, van Haren MA, Verhagen C, Hoekzema R, Kijlstra A (1994) Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Investig Ophthalmol Vis Sci 35:1100–1106
Fukuzawa M, Satoh J, Sagara M, Muto G, Muto Y, Nishimura S, Miyaguchi S, Qiang XL, Sakata Y, Nakazawa T, Ikehata F, Ohta S, Toyota T (1997) Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-α in vitro and in vivo. Immunopharmacology 36:49–55
Furukawa Y, Matsumori A, Hirozane T, Sasayama S (1996) Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril. Circulation 93:333–339
Godsel LM, Leon JS, Engman DM (2003a) Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis. Curr Pharm Des 9:723–735
Godsel LM, Leon JS, Wang K, Fornek JL, Molteni A, Engman DM (2003b) Captopril prevents experimental autoimmune myocarditis. J Immunol 171:346–352
Gregerson DS, Obritsch WF, Fling SP, Cameron JD (1986) S-antigen-specific rat T cell lines recognize peptide fragments of S-antigen and mediate experimental autoimmune uveoretinitis and pinealitis. J Immunol 136:2875–2882
Gu L, Tseng SC, Rollins BJ (1999) Monocyte chemoattractant protein-1. Chem Immunol 72:7–29
Hisada Y, Sugaya T, Yamanouchi M, Uchida H, Fujimura H, Sakurai H, Fukamizu A, Murakami K (1999) Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 103:627–635
Ilieva I, Ohgami K, Jin XH, Suzuki Y, Shiratori K, Yoshida K, Kase S, Ohno S (2006) Captopril suppresses inflammation in endotoxin-induced uveitis in rats. Exp Eye Res 83:651–657
Inokuchi Y, Morohashi T, Kawana I, Nagashima Y, Kihara M, Umemura S (2005) Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice. Gut 54:349–356
Kitamei H, Iwabuchi K, Namba K, Yoshida K, Yanagawa Y, Kitaichi N, Kitamura M, Ohno S, Onoé K (2006) Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-κB (NF-κB), pyrrolidine dithiocarbamate. J Leukoc Biol 79:1193–1201
Kramer C, Sunkomat J, Witte J, Luchtefeld M, Walden M, Schmidt B, Tsikas D, Boger RH, Forssmann WG, Drexler H, Schieffer B (2002) Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179. Circ Res 90:770–776
Kranzhofer R, Browatzki M, Schmidt J, Kubler W (1999) Angiotensin II activates the proinflammatory transcription factor nuclear factor-κB in human monocytes. Biochem Biophys Res Commun 257:826–828
Kurihara T, Ozawa Y, Shinoda K, Nagai N, Inoue M, Oike Y, Tsubota K, Ishida S, Okano H (2006) Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation. Investig Ophthalmol Vis Sci 47:5545–5552
Levens NR (1984) Modulation of jejunal ion and water absorption by endogenous angiotensin after dehydration. Am J Physiol 246:G700–G709
Li Q, Peng B, Whitcup SM, Jang SU, Chan CC (1995) Endotoxin induced uveitis in the mouse: susceptibility and genetic control. Exp Eye Res 61:629–632
Miyoshi M, Nagata K, Imoto T, Goto O, Ishida A, Watanabe T (2003) ANG II is involved in the LPS-induced production of proinflammatory cytokines in dehydrated rats. Am J Physiol Regul Integr Comp Physiol 284:R1092–R1097
Mochizuki M, Kuwabara T, McAllister C, Nussenblatt RB, Gery I (1985) Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features. Investig Ophthalmol Vis Sci 26:1–9
Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE (1991) Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351:233–236
Nagai N, Oike Y, Noda K, Urano T, Kubota Y, Ozawa Y, Shinoda H, Koto T, Shinoda K, Inoue M, Tsubota K, Yamashiro K, Suda T, Ishida S (2005) Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor. Investig Ophthalmol Vis Sci 46:2925–2931
Peeters AC, Netea MG, Kullberg BJ, Thien T, van der Meer JW (1998) The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology 94:376–379
Planck SR, Huang XN, Robertson JE, Rosenbaum JT (1994) Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment. Investig Ophthalmol Vis Sci 35:924–930
Price A, Lockhart JC, Ferrell WR, Gsell W, McLean S, Sturrock RD (2007) Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis. Arthritis Rheum 56:441–447
Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR (1980) Endotoxin-induced uveitis in rats as a model for human disease. Nature 286:611–613
Rossig L, Dimmeler S, Zeiher AM (2001) Apoptosis in the vascular wall and atherosclerosis. Basic Res Cardiol 96:11–22
Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, Lorenzo O, Plaza JJ, Egido J (1998) Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-κB activation and monocyte chemoattractant protein-1 synthesis. J Immunol 161:430–439
Sadoshima J (2002) Novel AT(1) receptor-independent functions of losartan. Circ Res 90:754–756
Sandberg K (1994) Structural analysis and regulation of angiotensin II receptors. TEM 5:28–35
Sasamura H, Hein L, Krieger JE, Pratt RE, Kobilka BK, Dzau VJ (1992) Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun 185:253–259
Shimizu H, Miyoshi M, Matsumoto K, Goto O, Imoto T, Watanabe T (2004) The effect of central injection of angiotensin-converting enzyme inhibitor and the angiotensin type 1 receptor antagonist on the induction by lipopolysaccharide of fever and brain interleukin-1β response in rats. J Pharmacol Exp Ther 308:865–873
Tanaka A, Matsumori A, Wang W, Sasayama S (1994) An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis. Circulation 90:2051–2055
Taylor AW, Yee DG, Nishida T, Namba K (2000) Neuropeptide regulation of immunity. The immunosuppressive activity of α-melanocyte-stimulating hormone (α-MSH). Ann NY Acad Sci 917:239–247
Tegeder I, Pfeilschifter J, Geisslinger G (2001) Cyclooxygenase-independent actions of cyclooxygenase inhibitors. Faseb J 15:2057–2072
Timmermans PB, Smith RD (1994) Angiotensin II receptor subtypes: selective antagonists and functional correlates. Eur Heart J 15(Suppl D):79–87
Tuaillon N, Shen DF, Berger RB, Lu B, Rollins BJ, Chan CC (2002) MCP-1 expression in endotoxin-induced uveitis. Investig Ophthalmol Vis Sci 43:1493–1498
Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima J, Kawamoto S, Ishigatsubo Y, Okubo T (1994) NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 153:2052–2063
Verma MJ, Lloyd A, Rager H, Strieter R, Kunkel S, Taub D, Wakefield D (1997) Chemokines in acute anterior uveitis. Curr Eye Res 16:1202–1208
Wang Y, Rangan GK, Goodwin B, Tay YC, Harris DC (2000) Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-κB dependent. Kidney Int 57:2011–2022
Wesselman JP, De Mey JG (2002) Angiotensin and cytoskeletal proteins: role in vascular remodeling. Curr Hypertens Rep 4:63–70
Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RA, Thaiss F (2002) Angiotensin II activates nuclear transcription factor-κB through AT1 and AT2 receptors. Kidney Int 61:1986–1995
Acknowledgements
This work was supported in part by Grants-in-Aid for Scientific Research (S), (B) and (C) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, by Grant-in-Aid for Scientific Research on Priority Areas from MEXT Japan, and by a Grant for Researches on Sensory and Communicative Disorders, Ministry of Health, Labour and Welfare, Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miyazaki, A., Kitaichi, N., Ohgami, K. et al. Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats. Graefes Arch Clin Exp Ophthalmol 246, 747–757 (2008). https://doi.org/10.1007/s00417-007-0730-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-007-0730-2